Clinical Trial Update: Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial completed evaluating whether adding rivastigmine to an exercise program improves quality of life in Alzheimer's disease patients. The study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Exelon (rivastigmine)

Snippet

Sponsor: Federal University of Bahia | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED